Oncology Patients clinical trials

Explore recruiting oncology patients clinical trials.

Recruiting oncology patients studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Oncology Patients trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Long Term Follow-Up of Patients Exposed to Lentiviral-Based CAR T-CellTherapy

Sweden, France, Finland, Netherlands, Austria, Norway +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Serial cardiac magnetic resonance imaging (CMR) with contrast agents and biomarker analysis for the detection of cardiotoxicity under anthracycline-containing cancer therapy - A monocentric, low interventional Phase IV pilot study

Germany

Therapeutic use (Phase IV) EU CTIS Study details

Cannabis extrAct in oncology Patients for the treatment of TUmor Related symptom burden (CAPTURE)

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Fractionated stereotactic radiotherapy plus second-generation antiandrogen for oligometastatic patients with castration-resistant prostate cancer. Phase II Spanish study, prospective, multicenter. (OLIGORESIST)

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Oncology Patients trials by city

Oncology Patients in Toronto Oncology Patients in Vancouver Oncology Patients in Montreal Oncology Patients in Calgary Oncology Patients in Edmonton Oncology Patients in Ottawa Oncology Patients in Winnipeg Oncology Patients in Quebec City Oncology Patients in Hamilton Oncology Patients in Kitchener Oncology Patients in London Oncology Patients in Halifax Oncology Patients in New York Oncology Patients in Los Angeles Oncology Patients in Chicago Oncology Patients in Houston

Oncology Patients clinical trials

Recruiting oncology patients studies right now

Efficacy of Preparation in Self-Hypnosis by Anchoring Versus Conversational Hypnosis, Used Alone or Combined, in Patients Undergoing Breast Macrobiopsies

Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Efficacy of BC2027 in Patients With Advanced Solid Malignancies

Evaluating Laser Photobiomodulation for the Treatment of Neuropathic Pain in Chemotherapy-induced Peripheral Neuropathy in Cancer Patients

A Randomized, Double-blind, Multicenter Phase III Study of XNW5004 Tablets in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

5G-PEARL: Paxalisib in Malignant Brain Tumours

Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy

225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome

A Multicenter, Randomized, Open-label, Parallel-group, Controlled, Superiority Phase III Clinical Study Comparing the Efficacy and Safety of F182112 Versus Standard of Care in Patients With Relapsed or Refractory Multiple Myeloma

Application of 3D MR Neurogram for Intraparotid Facial Nerves Evaluation

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

An Optimized Ultrasound Twinkling Marker for the Imaging of Lymph Nodes in Patients With Clinically Node-Positive Breast Cancer, The UTMOST2 Trial